Cited 27 times in
Cisplatin induces tolerogenic dendritic cells in response to TLR agonists via the abundant production of IL-10, thereby promoting Th2- and Tr1-biased T-cell immunity.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.